Patients were included in the study who were pseudophakic with center-involved (sub-foveal) diabetic macular edema
Patients were included in the study who were pseudophakic with center-involved (sub-foveal) diabetic macular edema. Those patients who had glaucoma history or IOP above 21 mm of Hg, Phakic, corneal opacity, vitreous hemorrhage, proliferative diabetic retinopathy, already received anti-VEGF injections, history of pan-retinal photocoagulation for proliferative diabetic retinopathy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
82
Intravitreal bevacizumab alone
Combination of Intravitreal bevacizumab and suprachoroidal triamcinolone acetonide
Khyber Teaching Hospital
Peshawar, Khyber Pakhtunkhwa, Pakistan
Central macular thickness
Effect of both treatment on central macular thickness measure on optical coherence tomography
Time frame: 3 months
Visual Acuity
Improvement in best corrected visual acuity
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.